advertisement

diseases & conditions

study uncovers potential new way to reverse nerve damage in multiple sclerosis, other neurological diseases

new breakthrough study looks to change the way ms and other neurological diseases are treated by reversing nerve fibre damage.
angelica bottaro
jul 5 2024

study links ingredient in artificial sweeteners to increased risk of heart attack and stroke

a recent study suggests ingredients in commonly-used sweeteners pose a greater risk for major adverse cardiovascular events (mace) such as heart attack and stroke.
raby nguer
jul 4 2024

leaders in health: dr. sasha high and teaching people why weight loss isn’t about food

dr. sasha high has embraced holistic-style treatments after more than a decade of learning and seeing the science of obesity medicine evolve.
karen hawthorne
jul 3 2024

ovarian cancer in canada: stats, impact and resources

ovarian cancer rates continue to rise in canada, with medical experts pushing for better prevention techniques to slow growth and improve outcomes.
karen hawthorne
jul 2 2024

hiv prevention drug shows 100 per cent efficacy for cisgender women in latest trial

the new injectable prep could make drug adherence easier for canadian cisgender women at risk of hiv, reducing the risk of transmission, and potentially, lower the number of new cases in the country.
angelica bottaro
jun 27 2024

what it feels like: ovarian cancer made me listen to my gut feelings

"when it comes to ovarian cancer, it’s so dependent on the human side of it in the sense that you don’t have very clear symptoms."
karen hawthorne
jun 26 2024

study uncovers genetic links to asthma inflammation, suggesting targeted therapy potential

the newly identified genetic pathway could pave the way for future asthma therapies that are more personalized and effective.
angelica bottaro
jun 25 2024

study reveals diabetes drug as potential treatment for obstructive sleep apnea

tirzepatide may be used for diabetes, but it's well on its way to becoming the first-ever drug therapy for obstructive sleep apnea (osa).
angelica bottaro
jun 25 2024
powered by
obesity canada
powered by
save your skin foundation

study uncovers potential new way to reverse nerve damage in multiple sclerosis, other neurological diseases

new breakthrough study looks to change the way ms and other neurological diseases are treated by reversing nerve fibre damage.
angelica bottaro
jul 5 2024

study links ingredient in artificial sweeteners to increased risk of heart attack and stroke

a recent study suggests ingredients in commonly-used sweeteners pose a greater risk for major adverse cardiovascular events (mace) such as heart attack and stroke.
raby nguer
jul 4 2024

leaders in health: dr. sasha high and teaching people why weight loss isn’t about food

dr. sasha high has embraced holistic-style treatments after more than a decade of learning and seeing the science of obesity medicine evolve.
karen hawthorne
jul 3 2024

ovarian cancer in canada: stats, impact and resources

ovarian cancer rates continue to rise in canada, with medical experts pushing for better prevention techniques to slow growth and improve outcomes.
karen hawthorne
jul 2 2024
powered by
obesity canada

hiv prevention drug shows 100 per cent efficacy for cisgender women in latest trial

the new injectable prep could make drug adherence easier for canadian cisgender women at risk of hiv, reducing the risk of transmission, and potentially, lower the number of new cases in the country.
angelica bottaro
jun 27 2024

what it feels like: ovarian cancer made me listen to my gut feelings

"when it comes to ovarian cancer, it’s so dependent on the human side of it in the sense that you don’t have very clear symptoms."
karen hawthorne
jun 26 2024

study uncovers genetic links to asthma inflammation, suggesting targeted therapy potential

the newly identified genetic pathway could pave the way for future asthma therapies that are more personalized and effective.
angelica bottaro
jun 25 2024

study reveals diabetes drug as potential treatment for obstructive sleep apnea

tirzepatide may be used for diabetes, but it's well on its way to becoming the first-ever drug therapy for obstructive sleep apnea (osa).
angelica bottaro
jun 25 2024

advertisement

advertisement